A CDC advisory panel meeting scheduled for December will discuss hepatitis B vaccination policy changes. The panel previously postponed a vote on delaying the vaccine's first dose for newborns.
Explore the latest on Kennedy and vaccination policy changes from the CDC's advisory committee meeting on December 4 and 5.
The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, known as GLP-1 medications, now cost as much as $1,350 a month. Under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback